Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Albelda

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 6, 2000
Effect of preexisting anti-herpes immunity on the efficacy of herpes simplex viral therapy in a murine intraperitoneal tumor modelE S Lambright, E H Kang, S Force, et al.
Thorax|March 18, 2000
Recent advances in molecular biological techniques and their relevance to pulmonary researchB W Robinson, D J Erle, D A Jones, et al.
The Journal of Experimental Medicine|July 1, 1996
An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membraneM W Wakelin, M J Sanz, A Dewar, et al.
Gene Therapy|June 27, 2001
Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacyE S Lambright, K Amin, R Wiewrodt, et al.
British Journal of Cancer|March 14, 2013
Using macrophage activation to augment immunotherapy of established tumoursZ G Fridlender, A Jassar, I Mishalian, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|September 1, 1993
Cell adhesion receptors and early mammalian heart development: an overviewC A Buck, H S Baldwin, H DeLisser, et al.
Cancer Research|April 15, 1994
Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization systemW R Smythe, H C Hwang, K M Amin, et al.
Virology|September 15, 1996
Herpes simplex 1716--an ICP 34.5 mutant--is severely replication restricted in human skin xenografts in vivoB P Randazzo, J C Kucharczuk, L A Litzky, et al.
Cancer Gene Therapy|April 19, 2000
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapyG Coukos, A Makrigiannakis, S Montas, et al.
Human Gene Therapy|January 20, 1996
Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase geneA A Elshami, J C Kucharczuk, H B Zhang, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 6, 2000
Effect of preexisting anti-herpes immunity on the efficacy of herpes simplex viral therapy in a murine intraperitoneal tumor modelE S Lambright, E H Kang, S Force, et al.
Thorax|March 18, 2000
Recent advances in molecular biological techniques and their relevance to pulmonary researchB W Robinson, D J Erle, D A Jones, et al.
The Journal of Experimental Medicine|July 1, 1996
An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membraneM W Wakelin, M J Sanz, A Dewar, et al.
Gene Therapy|June 27, 2001
Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacyE S Lambright, K Amin, R Wiewrodt, et al.
British Journal of Cancer|March 14, 2013
Using macrophage activation to augment immunotherapy of established tumoursZ G Fridlender, A Jassar, I Mishalian, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|September 1, 1993
Cell adhesion receptors and early mammalian heart development: an overviewC A Buck, H S Baldwin, H DeLisser, et al.
Cancer Research|April 15, 1994
Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization systemW R Smythe, H C Hwang, K M Amin, et al.
Virology|September 15, 1996
Herpes simplex 1716--an ICP 34.5 mutant--is severely replication restricted in human skin xenografts in vivoB P Randazzo, J C Kucharczuk, L A Litzky, et al.
Cancer Gene Therapy|April 19, 2000
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapyG Coukos, A Makrigiannakis, S Montas, et al.
Human Gene Therapy|January 20, 1996
Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase geneA A Elshami, J C Kucharczuk, H B Zhang, et al.
Pageof 15